What Analyst Recommend? Nektar Therapeutics (NKTR) stock is worth at $ $51.97

0 2

Nektar Therapeutics (NKTR):

Nektar Therapeutics (NKTR) closed its day with loss -1.18% and ended at the price of $51.97. NKTR stock is a part of Biotechnology industry and belongs to Healthcare sector. The stock traded volume of 3.73 million shares during its recent trading session while it’s an average volume stands around 1.93 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 1.99. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. The price to sales ratio is 17.

Analysts Opinion:

Analysts’ consensus recommendation is observed at 1.60. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.

Performance Check:

To evaluate the NKTR recent performance, look at its past history: the stock sticks almost 15.51% during last week. It showed the change of 119.65% in last one month. It remained at 171.95% over last 3 months. The stock performed 285.53% in last 12- months and its year to date performance is standing at 323.55%.

Technical Indicators:

Relative Strength Index (RSI) is 91.64 and ATR value of company is 2.68. The stock volatility for month is 7.12% and for week it is 6.59%.The stock traded 355.48% to its 52 week low and was changed -1.33% from its 52 week high as of last close. Beta factor, which measures the riskiness of the security, was observed as 1.27. NKTR’s value Change from Open was at -0.67% with a Gap of -0.51%.

USA based company Nektar Therapeutics (NKTR)’s latest closing price was 143.73% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 85.55% and 49.36% compared with the 20 Day Moving Average.

EPS Growth about NKTR:

EPS in next five year years is expected to touch -7.30% while EPS growth in past 5 year was 1.50% along with sales growth of 18.30% in the last five years.

EPS growth in next year is estimated to reach -25.70% while EPS growth estimate for this year is set at -79.50%.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.